ISWM logo
Submit Manuscript

Instructions to Authors

International Scope of Wound Management (ISWM) is published three times a year, in April, August, and December. Its aim is to publish high-quality basic and applied research articles on diagnosis, treatment, and prevention in the fields of diabetes-related foot problems and chronic wound care. Additionally, reviews, editorials, letters to the editor, and case reports are also accepted for publication.

The journal’s target audience includes all physicians, nurses, podiatrists, and professionals in related fields who are interested in diabetes-related foot problems and chronic wound care.

Articles are evaluated according to a “double-blind” peer-review system for both reviewers and authors.

No fees are charged to authors for the articles to be published in the journal.

Language

The journal’s language of publication is English

EDITORIAL AND PUBLICATION PROCESS

The editorial and publication processes of the journal are designed in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and the National Information Standards Organization (NISO); and are conducted in compliance with the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).

The Editor-in-Chief evaluates manuscripts regardless of the authors’ age, ethnicity, gender, nationality, religious beliefs, sexual orientation, or political opinions.

The opinions and reports expressed in all articles published in ISWM are those of the author(s). Therefore, the Editor, the Editorial Board, and the Publisher accept no responsibility or liability for these articles.

All manuscripts must be submitted via the online submission system after logging on to the website https://journal.dotdoc.com.tr/index.php/iswm/login.

PEER-REVIEW PROCESS

International Scope of Wound Management is an international journal based on the principles of independent and unbiased peer review. Manuscripts are evaluated according to a “double-blind” system for both reviewers and authors.

Authors submit their manuscripts through the ISWM online submission system. Manuscripts uploaded to the system are first checked from a technical perspective. The writing language, figures and tables, required documents (author contribution form, copyright approval form, patient consent for case reports, ethics committee approval), and references are reviewed, and a plagiarism check is performed. Manuscripts that pass this stage are directed to the Editor-in-Chief. The Editor-in-Chief evaluates whether the content is consistent with the journal’s publication policy, prepared according to the submission guidelines, and its scientific contribution to the field. Manuscripts passing this evaluation are forwarded to the Editor to initiate the scientific content review process.

The Editor assigns at least two reviewers through the system to evaluate the scientific content and provide suggestions, criticisms, and contributions. When deemed necessary, the manuscript is also directed to the Statistical Editor. Care is taken to select reviewers who are experts in the field and have no conflicts of interest with the authors. To prevent any bias, information regarding the authors and the institution where the study was conducted is hidden when the manuscript is sent to the reviewers. The reviewers’ suggestions, criticisms, and contributions are reviewed by the Editor and, if found sufficient, forwarded to the author. The Editor may direct the manuscript to additional reviewers if necessary. Reviewer names are kept confidential when forwarding feedback to the authors. This ensures that the scientific content of the manuscripts is evaluated objectively and without bias through the double-blind method.

Following the authors’ necessary revisions, the manuscript is sent back to the Editor and then to the reviewers for re-evaluation. Manuscripts deemed sufficient in this evaluation are accepted for publication. Manuscripts that reviewers do not find suitable for publication are rejected. Accepted manuscripts are reviewed by the English language editor and then typeset by the publisher; the typeset version is sent to the authors for final control and approval. Manuscripts that are ready for publication in this manner are published electronically on the journal’s website.

Additional Requirements & Disclosures

  • Financial Support: Any cash or in-kind support provided to the research, even if partial, must be reported as a footnote, identifying the institution, organization, or pharmaceutical/medical device company involved.
  • Originality: The work upon which the manuscript is based must not have been previously published elsewhere, nor submitted or accepted for publication. The finalized version of a preliminary report previously published as an abstract may be included. If a section of the text is requested to be removed, an application must be made in writing specifying the necessary change.
  • Withdrawal: If authors wish to withdraw a manuscript for any reason, they must apply with a letter explaining the reasons.
  • Anonymity: The name of the authors’ institution or the department/institution where the research was conducted should not be mentioned in the main text.
  • Corresponding Author: The corresponding author must clearly provide their contact information (telephone number, fax number, and e-mail address). The corresponding author’s information is published in the journal.
  • Record Keeping: Authors must keep a copy of everything they submit for publication.
  • Dual Publication: If all or any part of a submitted text is to be published elsewhere, the Editorial Office must be informed.

ETHICAL PROCEDURES

Approval of research protocols by the Ethics Committee, in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects,” amended in October 2013, www.wma.net), is required for experimental, clinical, and drug studies, as well as for some case reports. If required, ethics committee reports or an equivalent official document will be requested from the authors. For manuscripts concerning experimental research on humans, a statement should be included indicating that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures they may undergo. For studies involving animals, the measures taken to prevent pain and suffering should be clearly stated. Information on patient consent, the ethics committee name, and the ethics committee approval number should also be provided at the end of the manuscript. It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of patients, signed releases from the patient or their legal representative should be enclosed, and publication approval must be provided in the Materials and Methods section.

All submissions are screened using similarity-detection software.

In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE guidelines.

AUTHOR CONTRIBUTION

Each person listed as an author in the manuscript is expected to meet the authorship criteria recommended by the International Committee of Medical Journal Editors (ICMJE) (ICMJE – www.icmje.org).

The ICMJE recommends that authors meet the following four criteria:

  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;
  2. Drafting the work or revising it critically for important intellectual content;
  3. Final approval of the version to be published;
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

During the submission process, the corresponding author must complete the Author Contribution Form, indicating the specific contributions and the extent of involvement of each author at every stage, and upload it to the online submission system.

TRANSPARENCY DECLARATION

At the end of the manuscript, the information about the transparency declaration is presented:

  • Ethical Approval
  • Informed Consent
  • Peer-review
  • Author Contributions
  • Conflict of Interest
  • Financial Disclosure
  • Acknowledgment

CONFLICT OF INTERESTS

International Scope of Wound Management requires and encourages the authors and the individuals involved in the evaluation process of submitted manuscripts to disclose any existing or potential conflicts of interest, including financial, consultant, and institutional, that might lead to potential bias or a conflict of interest. Any financial grants or other support received for a submitted study from individuals or institutions should be disclosed to the Editorial Board. To disclose a potential conflict of interest, the ICMJE Potential Conflict of Interest Disclosure Form should be filled in and submitted by all contributing authors. Cases of a potential conflict of interest of the editors, authors, or reviewers are resolved by the journal’s Editorial Board within the scope of COPE and ICMJE guidelines.

The Editorial Board of the journal handles all appeal and complaint cases within the scope of COPE guidelines. In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor-in-Chief is the final authority in the decision-making process for all appeals and complaints.

COPYRIGHT

International Scope of Wound Management requires each submission to be accompanied by a Copyright License Agreement form.

By signing the Copyright License Agreement, the authors agree that the article, if accepted for publication by the ISWM, will be licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC 4.0).

CC BY-NC 4.0 license permits third parties to share and adapt the content for non-commercial purposes by giving the appropriate credit to the original work.

Authors must obtain permission from the copyright holder when using previously published content, including figures, tables, or any other material in both print and electronic formats. Legal, financial, and criminal liabilities in this regard belong to the author(s).

All opinions and reports within the articles that are published in the ISWM are the personal opinions of the author(s). Therefore, .doc (publisher) and ISWM, editor-in-chief, editorial board, and publisher do not accept any responsibility for these articles.

Authors retain unrestricted copyrights and publishing rights in ISWM.

USE OF LARGE LANGUAGE MODELS AND GENERATIVE AI TOOLS

AI tools cannot meet the requirements for authorship as they cannot take responsibility for the submitted work. As non-legal entities, they cannot assert the presence or absence of conflicts of interest, nor can they manage copyright and license agreements. Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent about how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.” COPE Position Statement on Authorship and AI tools. Detailed information about the statement can be accessed at https://publicationethics.org/cope-position-statements/ai-author

After reviewing the COPE statement, the editors of the ISWM have decided that papers should include a statement in a section called “Declaration Regarding the Use of AI and AI-Assisted Technologies” to let readers know if AI or AI-assisted tools were used in the writing process. It’s important to remember that all authors are responsible for the content of their work. This declaration does not apply to the use of basic tools for checking grammar, spelling, or references (such as Mendeley, EndNote, Zotero, and others). If there is nothing to declare, there is no need to add a statement.

It is suggested that authors follow this format when preparing their statement:

During the preparation of this work, the author(s) utilized [NAME OF TOOL(S) USED] to [DESCRIPTION OF HOW THE TOOL(S) WERE UTILIZED AND HOW THE VALIDITY OF THE OUTPUTS WAS EVALUATED]. After carefully reviewing and editing the content as necessary, full responsibility for the publication’s content is taken by the author(s). This incorporation of AI tool usage primarily impacted [SPECIFY WHICH ASPECTS OF THE STUDY, ARTICLE CONTENTS, DATA, OR SUPPORTING FILES WERE AFFECTED/GENERATED].

Example:

During the preparation of this work, the author(s) utilized OpenAI’s ChatGPT to generate summaries of research articles related to the topic. These summaries were evaluated by comparing them to manually written summaries by experts in the field. Upon confirming the accuracy and relevance of the generated summaries, they were integrated into the literature review section of the manuscript. After carefully reviewing and editing the content as necessary, full responsibility for the publication’s content is taken by the author(s). This incorporation of AI tools primarily improved the efficiency of the literature review process and the comprehensiveness of the gathered research insights.

MANUSCRIPT PREPARATION

The manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (updated in December 2018 – http://www.icmje.org/icmje-recommendations.pdf). Authors are required to prepare manuscripts in accordance with the CONSORT guidelines for randomized research studies, STROBE guidelines for observational original research studies, STARD guidelines for studies on diagnostic accuracy, PRISMA guidelines for systematic reviews and meta-analysis, ARRIVE guidelines for experimental animal studies, and TREND guidelines for non-randomized public behavior.

Manuscripts can only be submitted through the Journal’s online manuscript submission and evaluation system, available at https://journal.dotdoc.com.tr/index.php/iswm/submissions

Manuscripts submitted via any other medium will not be evaluated.

Manuscripts submitted to the journal will first undergo a technical evaluation, during which the editorial office staff will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests.

Authors are required to submit the following:

  • Copyright Agreement Form, and
  • Author Contributions Form.

MANUSCRIPT REQUIREMENTS

Title: The title of your manuscript should attract attention, accurately describes the contents of your manuscript, and makes people want to read further.

Your title should:

  • Include the main topics of the study.
  • Highlight the importance of your research.
  • Be concise and canonic; avoid unnecessary words.
  • Attract readers, but avoid exclamation marks.

Title page: A separate title page should be submitted with all submissions, and this page should include:

  • The full title of the manuscript, as well as a short title (running head) of no more than 50 characters,
  • Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s),
  • Grant information and detailed information on the other sources of support,
  • Name, address, telephone (including the mobile phone number), and email address of the corresponding author,
  • Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria.

Abstract: Your Abstract should cover these questions about your manuscript:

  • Why did you intend to do such a study? Describe your background in 1 to 2 sentences.
  • What was your aim? Describe your aim in one sentence.
  • How did you do? Explain your methods by providing a precise, clear definition of the study population, study duration, centers, intervention, and, if applicable, the comparator.
  • What did you find? Give the most striking results of your study by including statistical measures such as effect estimates (relative risk, odds ratio, hazard ratio) and confidence intervals and/or p values.
  • What should the reader take from your study? In conclusion, avoid generic words and sentences, and give the conclusions from your study findings.

Keywords: Each submission must be accompanied by a minimum of three to a maximum of six keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations. The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).

Highlights: Each submission of Original Articles can be accompanied by 3 to 5 “highlights” which should emphasize the most remarkable results of the study and underline the primary message that is addressed to the reader. As this section would be targeting specialists and experts in the field, they should be kept as plain and simple as possible. This section should be constructed as point by point, which provides a general overview of the article.

MANUSCRIPT TYPES

Original Articles 

Manuscripts submitted must contain original research not published elsewhere, even partially, except as summaries of fewer than 400 words for scientific meetings. A research article should be prepared as follows:

  • Title page: The title page should include the following:
  • Title of the manuscript, as concise and explanatory as possible, including no abbreviations, up to 135 characters
  • Short title, up to 60 characters
  • Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s)
  • Grant information and detailed information on the other sources of support
  • Name, address, telephone (including the mobile phone number), and email address of the corresponding author
  • The name of the institution that made the ethics committee decision, the date, and the number of the decision should be stated (if applicable).
  • The structured abstract: It should include the following subheadings: Objective, Materials and Methods, Results, Conclusions, and Keywords. The word limit is 300.
  • Keywords: A minimum of three to a maximum of six keywords should be in accordance with the National Library of Medicine, Medical Subject Headings database.
  • Main Text: The main text of the original article can be divided into subheadings: Introduction, Materials and Methods, Results, Discussion, and Conclusion. The word limit is 5000. The methods section should include the board and date/number from which the ethics committee approval was obtained.
  • References: The number of references should not exceed 50. The style for references is based mainly on an American National Standards Institute style (http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=citmed.TOC&depth=2).
  • Tables and Figures: If available, they should be consecutively numbered in the order they are referred to within the main text; each should be given a short title, and the title should be placed at the top of the tables and below the figures. Table limit: 6, Figure limit: 7 with a maximum of 15 subfigures/subunits.
  • Copyright Agreement Form: All authors must sign the form.
  • Author Contribution Form: As stated in the “Author Contribution Form”, a person must be named in at least three contributing fields to be accepted as an author. You can use abbreviated author names within the form. For example, you can use “MAÖ” instead of “Metin Ahmet Özdemir”.

Review Articles 

International Scope of Wound Management accepts review articles, upon the invitation of the Editor-in-Chief, from people who have in-depth knowledge in their field, are nationally and internationally known for their work in a certain field in their professional life, and have many cited publications in that field. It is expected that these reviews will summarize the current state of knowledge on a specific topic, identify existing knowledge gaps, and shed light on future research, while also providing valuable perspectives for professionals working in the fields of diagnosis, treatment, and prevention related to diabetes-associated foot problems and chronic wound care.

A review article should be prepared as follows:

  • Title page: The title page should include the following:
  • Title of the manuscript, as concise and explanatory as possible, including no abbreviations, up to 135 characters
  • Short title, up to 60 characters
  • Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s)
  • Grant information and detailed information on the other sources of support
  • Name, address, telephone (including the mobile phone number), and email address of the corresponding author
  • Abstract: Unstructured abstract with a word limit of 100.
  • Keywords: A minimum of three to a maximum of six keywords should be in accordance with the National Library of Medicine, Medical Subject Headings database.
  • Highlights: It is a 4-5-item section that includes the most remarkable headings of the current knowledge in clinical practice and/or scientific development, the most critical unanswered questions, and/or scientific predictions. It should consist of a maximum of 150 words.
  • Main Text: The review article’s main text can be divided into subheadings as the author deems appropriate (word limit: 7000).
  • References: The number of references should not exceed 100. The style for references is based mainly on an American National Standards Institute style (http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=citmed.TOC&depth=2).
  • Tables and Figures: If available, they should be consecutively numbered in the order they are referred to within the main text; each should be given a short title, and the title should be placed at the top of the tables and below the figures. Table limit: 6, Figure limit: 10 with a maximum of 20 subfigures/subunits.
  • Copyright Agreement Form: All authors must sign the form.
  • Author Contribution Form: As stated in the “Author Contribution Form”, a person must be named in at least three contributing fields to be accepted as an author. You can use abbreviated author names within the form. For example, you can use “MAÖ” instead of “Metin Ahmet Özdemir”.

Case Reports

Case reports are special features on clinical research with prominently specific objectives and results, small patient series with a limited number of observations, and descriptive epidemiological studies. A case study should be prepared as follows:

  • Title page: Your title page should include the following:
  • Title of the manuscript, as concise and explanatory as possible, including no abbreviations, up to 135 characters
  • Short title, up to 60 characters
  • Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s)
  • Grant information and detailed information on the other sources of support
  • Name, address, telephone (including the mobile phone number), and email address of the corresponding author
  • Written consent from the patient must be provided, or a declaration must be made that consent has been obtained from the patient.
  • Abstract: Unstructured abstract with a word limit of 100.
  • Keywords: A minimum of two to a maximum of four keywords should be in accordance with the National Library of Medicine, Medical Subject Headings database.
  • Main Text: It should be structured as “Introduction, Case (s), Discussion” sections, with a maximum of 1000 words.
  • References: The number of references should not exceed 10. The style for references is based mainly on an American National Standards Institute style (http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=citmed.TOC&depth=2).
  • Tables and Figures: If available, they should be consecutively numbered in the order they are referred to within the main text. Each should be given a short title, which should appear at the top of the tables and below the figures. The number of tables or figures should not be more than five.
  • Copyright Agreement Form: All authors must sign the form.
  • Author Contribution Form: As stated in the “Author Contribution Form”, a person must be named in at least three contributing fields to be accepted as an author. You can use abbreviated author names within the form. For example, you can use “MAÖ” instead of “Metin Ahmet Özdemir”.

Consensus Report and Clinical Guideline

The journal welcomes consensus reports and clinical guidelines related to the diagnosis, treatment, and prevention of chronic wounds. These manuscripts are typically developed through the broad participation of experts with diverse experience and perspectives, aiming to define priorities, clarify clinical recommendations, and support policy development.

Such documents should critically evaluate current scientific evidence and present an agreed-upon text in a clear, accessible, and timely manner for all relevant stakeholders.

The following instructions should guide the preparation of Consensus Reports/Guideline articles:

  • Unstructured Abstracts: Provide Turkish and English abstracts of no more than 150 words.
  • Keywords: Include 3–6 keywords in Turkish and English, in alignment with the Medical Subject Headings (MeSH) by the National Library of Medicine (NLM).
  • Main Text:
  • Introduction: Include the aim, general framework, target audience, and geographical scope of the study. If the study is an update, explain the need for the update and summarize the key differences and changes from the previous study, using visual aids like tables or infographics if necessary.
  • Methods: Describe the roles and specialties of those conducting the study, along with the inclusion criteria. Summarize the material used, its scope, and selection criteria. Clearly state the methods and techniques employed (e.g., Delphi, RAND-UCLA, nominal group technique). Indicate the historical scope of the study.
  • Use consistent language and terminology throughout the text.
  • Conflict of Interest: Disclose any potential conflicts of interest involving study directors and panelists. Provide details on how these conflicts were managed.
  • References: References should follow the specified style and have no numerical limit.
  • Tables, Figures, and Images: Number these consecutively based on their order in the text. Provide descriptive titles above tables and below figures and images. If sourced from other publications, ensure proper permissions and citations are obtained and indicated. Patient images may be used only with prior consent.

Opinion Essay/Report

These articles present opinions or reports on current key issues from institutions or individuals with recognized expertise in the fields of diagnosis, treatment, and prevention related to diabetes-associated foot disorders and chronic wound care. It is published after editorial evaluation, without peer review. There is no word or reference limit. The opinions in such articles bind the author, and the criticisms and contributions of the journal readers regarding the opinion will also be published under the same title after an editorial evaluation. Thus, it aims to provide a platform for scientific discussion of important issues in the field.

Letters to the Editor

A Letter to the Editor is published in order to express the opinions of the readers about an article published in ISWM or to express an opinion on any subject that is of interest to ISWM. The letter should start with ‘To the Editor’ or ‘Dear Editor’. A Letter to the editor should be prepared as follows:

  • Title page: Your title page should include the following:
  • Title of the manuscript, as concise and explanatory as possible, including no abbreviations, up to 135 characters
  • Short title, up to 60 characters
  • Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s)
  • Grant information and detailed information on the other sources of support
  • Name, address, telephone (including the mobile phone number), and email address of the corresponding author
  • Main Text: Submissions should not exceed 500 words.
  • References: The number of references should not exceed 5. The style for references is based mainly on an American National Standards Institute style (http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=citmed.TOC&depth=2).
  • Tables and Figures: This type of manuscript contains at most one table or figure.
  • Copyright Agreement Form: The form must be signed by all authors.
  • Author Contribution Form: As stated in the “Author Contribution Form”, a person must be named in at least three contributing fields to be accepted as an author. You can use abbreviated author names within the form. For example, you can use “MAÖ” instead of “Metin Ahmet Özdemir”.

Editorial

Editorial is an opinion letter written by an expert scientist in the field of the article, upon the invitation of the Editor-in-Chief, regarding an original article in ISWM. The editorial is expected to summarize the findings in the relevant article and include its contribution to the field of science and future views.

An editorial should be prepared as follows:

  • Title Page
  • Main Text: It should not be subdivided into subheadings and should contain a maximum of 500 words.
  • References: Detailed rules below should be followed, and the number of references should not exceed 5.
  • Tables and Figures: This type of manuscript contains at most one table or figure.

TABLES

Tables should be included in the main document, presented after the reference list, and they should be numbered consecutively in the order they are referred to within the main text. A descriptive title must be placed above the tables. Abbreviations used in the tables should be defined below the tables by footnotes (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software, and they should be arranged clearly to provide easy reading. Data presented in the tables should not duplicate that in the main text, but should support it.

FIGURES AND FIGURE LEGENDS

Figures, graphics, and photographs should be submitted as separate files (in TIFF or JPEG format) through the submission system. The files should not be embedded in the main Word document. When there are figure subunits, they should not be merged into a single image. Each subunit should be submitted separately through the submission system. Images should not be labeled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends. Like the rest of the submission, the figures should also be blinded. Any information within the images that may indicate an individual or institution should be blinded. Each submitted figure should have a minimum resolution of 300 DPI. To prevent delays in the evaluation process, all submitted figures should be high-resolution and large (minimum dimensions: 100×100 mm). Figure legends should be listed at the end of the main document.

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the definition.

When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in the USA), should be provided in parentheses in the following format: “Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)”.

All references, tables, and figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text.

Limitations, drawbacks, and shortcomings of original articles should be mentioned in the Discussion section before the conclusion paragraph.

REFERENCES

While citing publications, preference should be given to the latest, most up-to-date publications. If an ahead-of-print publication is cited, the DOI number should be provided. Authors are responsible for the accuracy of references. Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/ MEDLINE/PubMed. When there are six or fewer authors, all authors should be listed. If there are seven or more authors, the first six authors should be listed followed by “et al.” In the main text of the manuscript, references should be cited using Arabic numbers in parentheses. The reference styles for different types of publications are presented in the following examples:

The reference style is based on the National Library of Medicine (NLM) “Citing Medicine” style. https://www.ncbi.nlm.nih.gov/books/NBK7256/

Journal titles should be abbreviated according to the List of Journals Indexed for MEDLINE. https://www.ncbi.nlm.nih.gov/nlmcatalog/journals

Journal Article: Ben-Chetrit E, Oster Y, Jarjou’i A, Megged O, Lachish T, Cohen MJ, et al. Measles-related hospitalizations and associated complications in Jerusalem, 2018-2019. Clin Microbiol Infect. 2020;26(5):637-42. [CrossRef]

Epub Ahead of Print Articles: Cai L, Yeh BM, Westphalen AC, Roberts JP, Wang ZJ. Adult living donor liver imaging. Diagn Interv Radiol. Feb 24, 2016. [Epub ahead of print]. https://doi.org/10.5152/dir.2016.15323.

Manuscripts as preprints: Madewell ZJ, Yang Y, Jr IML, Halloran ME, Dean NE. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv [Preprint]. July 11, 2020. [CrossRef]

Supplement Article:Zöllner C, Lutz K, Demir M, Tacke F. First real-life experiences with 2 mg bulevirtide for the treatment of hepatitis delta-data from a tertiary reference centre in Germany. J Hepatol 2021;75(Suppl. 2):745-6.

Book Section: Suh KN, Keystone JS. Malaria and babesiosis. Gorbach SL, Barlett JG, Blacklow NR, editors. Infectious Diseases. Philadelphia: Lippincott Williams; 2004.p.2290-308.

Books with a Single Author: Sweetman SC. Martindale the Complete Drug Reference. 34th ed. London: Pharmaceutical Press; 2005. 

Books with Editor(s) as Author: Huizing EH, de Groot JAM, editors. Functional reconstructive nasal surgery. Stuttgart-New York: Thieme; 2003.

Book on the Internet: Chakraborty RK, Burns B. Systemic inflammatory response syndrome [Internet]. In: Treasure Island (FL), StatPearls Publishing; May 29, 2023 [cited November 12, 2024]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547669/

Book on the Internet with Editors: McKay LI, Cidlowski JA. Physiologic and pharmacologic effects of corticosteroids [Internet]. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei cancer medicine. 6th ed. Hamilton (ON): BC Decker; 2003. Available from: https://www.ncbi.nlm.nih.gov/books/NBK13780

Conference Proceedings: Bertagnolio S, Thwin S, Silva R, Ford N, Baggaley R, Vitoria M, et al. Clinical characteristics and prognostic factors in people living with HIV hospitalized with COVID-19: findings from the WHO Global Clinical Platform [Abstract]. In: Abstracts of 11th International AIDS Society (IAS) Conference on HIV Science (July 18-21, 2021).

Scientific or Technical Report: Cusick M, Chew EY, Hoogwerf B, Agrón E, Wu L, Lindley A, et al. Early Treatment Diabetic Retinopathy Study Research Group. Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Kidney Int: 2004. Report No: 26.

Thesis: McCracken Jenna Mae. Mechanisms and consequences of neutrophil apoptosis inhibition by Francisella tularensis [PhD thesis]. University of Iowa; 2017.

Websites with Organization / Corporate Author(s): World Health Organization. Crimean-Congo haemorrhagic fever [Internet]. Geneva: WHO; February 20, 2025. [cited March 6, 2026]. Available from: https://www.who.int/news-room/fact-sheets/detail/crimean-congo-haemorrhagic-fever

Websites with authors or editors: Shah A, Checkley W. Tularemia [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. [cited March 6, 2026]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430905/ 

REPOSITORY POLICY

International Scope of Wound Management uses Open Journal System (OJS), a journal management system, and archives the submitted, revised, accepted, and published versions of manuscripts on OJS. Authors are allowed to reach all these versions without any embargo.

ARCHIVING POLICY

The content published by ISWM is electronically preserved using the Internet Archive (https://archive.org/details/iswn-journal) to ensure its availability to scientists and researchers.

Share
Copy Link
×